Marathon Capital Management’s Stereotaxis STXS Stock Holding History
Bought
Maintained
Sold
Other funds holding STXS
DCM
LIM
APCM
RG
ACM
EIM
PGCM
Marathon Capital Management's STXS Position: Q2 2024 in Review
Marathon Capital Management sold out of Stereotaxis (STXS) in Q2 2024, closing a stake of 12,250 shares — an estimated $37.7K sold.
Marathon Capital Management first reported a position in STXS in Q1 2020 and held it in 17 quarters. The position peaked at $1.42M in Q2 2021. 73 funds tracked by Wall St. Rank hold STXS as of Q2 2024.
- Marathon Capital Management reported no remaining Stereotaxis position as of Q2 2024 after selling out during the quarter.
- Marathon Capital Management sold 12,250 Stereotaxis shares in Q2 2024, an estimated $37.7K.
- Marathon Capital Management first reported a position in Stereotaxis in Q1 2020 and held it in 17 quarters.
- Marathon Capital Management's Stereotaxis position peaked at $1.42M in Q2 2021.
- 73 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2024.
Based on Marathon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.